Company Filing History:
Years Active: 2023
Title: In-Cheol Sun: Innovator in Cancer Immunotherapy
Introduction
In-Cheol Sun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer immunotherapy through his innovative research and development of advanced nanoparticles.
Latest Patents
In-Cheol Sun holds a patent for "Visible light-activatable nanoparticles for cancer immunotherapy and use thereof." This patent discloses visible light-activatable antitumor self-assembled nanoparticles that induce potent apoptosis in cancer cells. These nanoparticles also enhance their own anticancer immunogenicity, thereby maximizing therapeutic efficacy against cancer.
Career Highlights
In-Cheol Sun is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work focuses on developing novel therapeutic strategies to combat cancer, utilizing cutting-edge technology and innovative approaches.
Collaborations
Some of his notable coworkers include Kwangmeyung Kim and Man Kyu Shim, who contribute to the collaborative efforts in advancing cancer treatment technologies.
Conclusion
In-Cheol Sun's work in developing visible light-activatable nanoparticles represents a significant advancement in cancer immunotherapy. His innovative approach has the potential to improve treatment outcomes for cancer patients.